NYSE - Delayed Quote • USD
Edwards Lifesciences Corporation (EW)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 5:59 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 810,445 | 34 |
| Sales | 418,344 | 30 |
| Net Shares Purchased (Sold) | 392,101 | 64 |
| Total Insider Shares Held | 5.33M | -- |
| % Net Shares Purchased (Sold) | 7.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LIPPIS DANIEL J Officer | Sale at price 92.34 per share. | Direct | 79,135 | Apr 9, 2024 |
| LIPPIS DANIEL J Officer | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 31,495 | Apr 9, 2024 |
| BOBO DONALD E JR Officer | Sale at price 92.33 - 92.66 per share. | Direct | 1,154,142 | Apr 8, 2024 |
| BOBO DONALD E JR Officer | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 459,375 | Apr 8, 2024 |
| LEMERCIER JEAN-LUC M Officer | Sale at price 92.32 - 92.65 per share. | Direct | 1,329,472 | Apr 8, 2024 |
| LEMERCIER JEAN-LUC M Officer | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 529,200 | Apr 8, 2024 |
| MUSSALLEM MICHAEL A Director | Sale at price 91.54 - 94.19 per share. | Direct | 2,712,418 | Apr 4, 2024 |
| MUSSALLEM MICHAEL A Director | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 1,078,612 | Apr 4, 2024 |
| ULLEM SCOTT B Chief Financial Officer | Sale at price 94.81 - 95.51 per share. | Direct | 688,423 | Apr 1, 2024 |
| ULLEM SCOTT B Chief Financial Officer | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 266,621 | Apr 1, 2024 |
| BOBO DONALD E JR Officer | Sale at price 91.01 per share. | Direct | 1,319,696 | Mar 13, 2024 |
| BOBO DONALD E JR Officer | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 532,875 | Mar 13, 2024 |
| LEMERCIER JEAN-LUC M Officer | Sale at price 91.68 per share. | Direct | 1,320,149 | Mar 11, 2024 |
| LEMERCIER JEAN-LUC M Officer | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 529,200 | Mar 11, 2024 |
| LIPPIS DANIEL J Officer | Sale at price 90.98 per share. | Direct | 156,031 | Mar 7, 2024 |
| LIPPIS DANIEL J Officer | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 63,026 | Mar 7, 2024 |
| MUSSALLEM MICHAEL A Director | Sale at price 86.21 - 87.05 per share. | Direct | 2,543,737 | Mar 4, 2024 |
| MUSSALLEM MICHAEL A Director | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 1,078,612 | Mar 4, 2024 |
| ULLEM SCOTT B Chief Financial Officer | Sale at price 85.59 per share. | Direct | 620,923 | Feb 29, 2024 |
| ULLEM SCOTT B Chief Financial Officer | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 266,621 | Feb 29, 2024 |
| GALLAHUE KIERAN T. Director | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 23, 2024 |
| GALLAHUE KIERAN T. Director | Sale at price 87.61 per share. | Indirect | 267,911 | Feb 23, 2024 |
| GALLAHUE KIERAN T. Director | Conversion of Exercise of derivative security at price 36.86 per share. | Direct | 260,107 | Feb 23, 2024 |
| SZYMAN CATHERINE M Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 22, 2024 |
| SELLERS ROBERT W A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 22, 2024 |
| CHOPRA DAVEEN Officer | Sale at price 86.67 - 86.75 per share. | Direct | 711,272 | Feb 21, 2024 |
| CHOPRA DAVEEN Officer | Conversion of Exercise of derivative security at price 59.26 per share. | Direct | 414,797 | Feb 21, 2024 |
| SZYMAN CATHERINE M Officer | Sale at price 85.62 - 86.46 per share. | Direct | 4,040,854 | Feb 15, 2024 |
| SZYMAN CATHERINE M Officer | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 1,727,250 | Feb 15, 2024 |
| BOBO DONALD E JR Officer | Sale at price 85.81 - 86.35 per share. | Direct | 944,155 | Feb 13, 2024 |
| BOBO DONALD E JR Officer | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 404,250 | Feb 13, 2024 |
| SELLERS ROBERT W A Officer | Sale at price 87.00 per share. | Direct | 1,062,270 | Feb 12, 2024 |
| SELLERS ROBERT W A Officer | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 448,718 | Feb 12, 2024 |
| STONE HEISZ LESLIE Director | Sale at price 86.45 per share. | Direct | 609,991 | Feb 8, 2024 |
| STONE HEISZ LESLIE Director | Conversion of Exercise of derivative security at price 36.86 per share. | Direct | 260,107 | Feb 8, 2024 |
| MUSSALLEM MICHAEL A Director | Sale at price 86.44 - 89.61 per share. | Direct | 2,567,754 | Feb 5, 2024 |
| MUSSALLEM MICHAEL A Director | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 1,078,612 | Feb 5, 2024 |
| ULLEM SCOTT B Chief Financial Officer | Sale at price 78.29 per share. | Direct | 567,994 | Feb 1, 2024 |
| ULLEM SCOTT B Chief Financial Officer | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 266,621 | Feb 1, 2024 |
| BOBO DONALD E JR Officer | Sale at price 75.67 per share. | Direct | 756,700 | Jan 12, 2024 |
| BOBO DONALD E JR Officer | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 367,500 | Jan 12, 2024 |
| MUSSALLEM MICHAEL A Director | Sale at price 72.94 - 73.46 per share. | Direct | 2,142,089 | Jan 5, 2024 |
| MUSSALLEM MICHAEL A Director | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 1,078,612 | Jan 5, 2024 |
| ULLEM SCOTT B Chief Financial Officer | Sale at price 76.55 per share. | Direct | 1,110,794 | Dec 29, 2023 |
| ULLEM SCOTT B Chief Financial Officer | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 533,242 | Dec 29, 2023 |
| CHOPRA DAVEEN Officer | Sale at price 78.25 per share. | Direct | 547,724 | Dec 15, 2023 |
| CHOPRA DAVEEN Officer | Conversion of Exercise of derivative security at price 59.26 per share. | Direct | 414,797 | Dec 15, 2023 |
| MUSSALLEM MICHAEL A Director | Sale at price 73.15 - 75.73 per share. | Direct | 2,190,043 | Dec 13, 2023 |
| MUSSALLEM MICHAEL A Director | Conversion of Exercise of derivative security at price 36.75 per share. | Direct | 1,078,612 | Dec 13, 2023 |
| BOBO DONALD E JR Officer | Sale at price 71.86 per share. | Direct | 574,880 | Dec 13, 2023 |
Related Tickers
DXCM DexCom, Inc.
124.34
-9.91%
BSX Boston Scientific Corporation
73.17
-0.12%
SYK Stryker Corporation
335.61
-0.46%
MDT Medtronic plc
79.74
+0.62%
ALGN Align Technology, Inc.
309.02
-0.48%
PODD Insulet Corporation
166.19
+1.23%
SWAV Shockwave Medical, Inc.
330.00
+0.31%
ABT Abbott Laboratories
107.53
+0.63%
NARI Inari Medical, Inc.
38.42
+0.92%
CNMD CONMED Corporation
65.78
+6.27%